that the Strecker reaction of phenylacetaldehyde with (R)-
phenylglycinol gave a 1+1 ratio of isomers. The poor selectivity
was attributed to steric factors. Compound 14 on reaction with
(R)-phenylglycinol in chloroform at rt overnight gave the imine
which on reaction with Me3SiCN at rt for 10 h followed by
treatment with tetrabutylammonium fluoride gave the amino
nitriles 15 and 16 in a 4+1 ratio in 66% yield over the three steps.
The amino nitriles 15 and 16 were easily separated by column
chromatography. The structure of the isomer 15 was confirmed
by X-ray crystallography. This compound was subjected to
acidic hydrolysis to afford the ester 17 in 81% yield based on
recovered starting material. No cyclization product was formed
in the hydrolysis reaction, thus supporting our choice of
protecting group. Oxidative removal of the phenylglycinol
moiety was carried out with lead tetraacetate in CH2Cl2–MeOH
to give a Schiff’s base, which on catalytic hydrogenation over
Pd(OH)2/C gave the free amine. The amine was isolated as the
BOC-protected intermediate 18, and the overall yield for the
three steps was 44%.
Notes and references
1 (a) Y. Nishizuka, Science, 1992, 258, 607; (b) Y. Nishizuka, Nature,
1988, 334, 661; (c) S. Bhagavan, D. Ibarreta, D. Ma, A. P. Kozikowski
and R. Etcheberrigaray, Neurobiol. Disease, 1998, 5, 177.
2 (a) Y. Endo, K. Shudo and T. Okamoto, Chem. Pharm. Bull., 1982, 30,
3457; (b) Y. Endo, K. Shudo, K. Furuhata, H. Ogura, S. Sakai, N. Aimi,
Y. Hitotsuyanagi and Y. Koyama, Chem. Pharm. Bull., 1984, 32, 358;
(c) K. Irie, T. Isaka, Y. Iwata, Y. Yanai, Y. Nakamura, F. Koizumi, H.
Ohigashi, P. A. Wender, Y. Satomi and H. Nishino, J. Am. Chem. Soc.,
1996, 118, 10733.
3 (a) Y. Endo, M. Ohno, M. Hirano, A. Itai and K. Shudo, J. Am. Chem.
Soc., 1996, 118, 1841; (b) A. P. Kozikowski, S. Wang, D. Ma, J. Yao,
S. Ahmad, R. I. Glazer, K. Bogi, P. Acs, S. Modarres, N. E. Lewin and
P. M. Blumberg, J. Med. Chem., 1997, 40, 1316.
4 D. Ma, T. Zhang, G. Wang, A. P. Kozikowski, N. E. Lewin and P. M.
Blumberg, Bioorg. Med. Chem. Lett., 2001, 11, 99.
5 (a) Chem. Abstr., 1955, 49, 3880; (b) Z. Budesinsky and E. Rockova,
Chem. Listy, 1954, 48, 427.
6 Compound 10 after a sequence of reactions as reported in Scheme 1
gave compound A, which on acid hydrolysis gave lactam B.
With the substituted phenylalanine fragment in hand, we now
needed to add the valine fragment. Compound 18 was reduced
to alcohol 19 using LiBH4 in THF in near quantitative yield.
The aromatic amino group was unmasked in good yield by
i
refluxing in a solvent mixture of PrOH–H2O with hydrox-
ylamine hydrochloride and triethylamine. The aniline 20 was
reacted with the
-valine derived triflate 219 to give compound
D
22 in 87% yield. Compound 22 on hydrogenation gave the
carboxylic acid in quantitative yield, which was converted to the
eight-membered lactam using the active ester method as
reported previously.3b N-Methylation using HCHO–
NaCNBH3–HOAc gave 7-methoxybenzolactam 4 in 87%
yield.10
In conclusion, we report an improved synthesis of
7-methoxybenzolactam-V8 making use of a diastereoselective
Strecker synthesis. This compound may serve as an inter-
mediate in the preparation of a variety of C7-substituted
benzolactam analogs, which may exhibit better isozyme
selectivity.
7 J. E. Macor, B. L. Chenard and R. J. Post, J. Org. Chem., 1994, 59,
7496.
8 T. K. Chakraborty, A. Hussain and G. V. Reddy, Tetrahedron, 1995, 51,
9179.
9 T. P. Kogan, T. C. Somers and M. C. Venuti, Tetrahedron, 1990, 46,
6623.
10 Selected data for compound 4: [a]2D2 2 262° (c 0.6, CHCl3), lit4: [a]2D2
2 275° (c 0.82, CHCl3); 1H NMR (300 MHz, CDCl3) d 7.12 (1H, t, J
= 8.3 Hz), 6.65 (1H, d, J = 8.0 Hz), 6.61 (1H, br s), 6.49 (1H, d, J =
8.0 Hz), 4.36 (1H, s), 3.80 (3H, s), 3.71 (1H, dd, J = 10.9, 4.2 Hz), 3.57
(1H, d, J = 8.5 Hz), 3.50 (1H, d, J = 9.3 Hz), 3.24 (1H, d, J = 17.5 Hz),
2.80 (3H, s), 2.76–2.64 (2H, m), 2.45–2.38 (1H, m), 1.04 (3H, d, J = 6.3
Hz), 0.83 (3H, d, J = 6.9 Hz); 13C NMR (CDCl3) d 19.7, 20.7, 27.8,
28.2, 34.9, 54.2, 55.6, 66.4, 69.7, 103.4, 112.3, 118.7, 127.3, 157.9,
173.9.
We are indebted to the National Institutes of Health for
support of this work (CA 79601).
476
Chem. Commun., 2001, 475–476